Mitsubishi Tanabe Of Japan Soon To See Rewards Of Old Novartis Tie
This article was originally published in PharmAsia News
Executive Summary
Japan's Mitsubishi Tanabe is expected to begin reaping the rewards soon of a licensing deal it negotiated more than a dozen years ago with Novartis, the Swiss drug maker